# MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns]

> **NCT06299878** · — · UNKNOWN · sponsor: **Russian Academy of Medical Sciences** · enrollment: 72 (estimated)

## Conditions studied

- Melanoma, Skin
- Melanoma Stage Iii

## Interventions

- **DIAGNOSTIC_TEST:** Gut microbiota analysis

## Key facts

- **NCT ID:** NCT06299878
- **Lead sponsor:** Russian Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-07-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06299878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06299878, "MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns]". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06299878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*